BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8324652)

  • 1. Interleukin-7: biology and potential clinical applications.
    Appasamy PM
    Cancer Invest; 1993; 11(4):487-99. PubMed ID: 8324652
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-7, a major T-lymphocyte cytokine.
    Costello R; Imbert J; Olive D
    Eur Cytokine Netw; 1993; 4(4):253-62. PubMed ID: 8268415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-7 and lymphopoiesis: biological and clinical implications.
    Appasamy PM
    Cancer Treat Res; 1995; 80():235-60. PubMed ID: 8821580
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-7: from bench to clinic.
    Fry TJ; Mackall CL
    Blood; 2002 Jun; 99(11):3892-904. PubMed ID: 12010786
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of lymphocytes in interleukin 7-transgenic mice.
    Samaridis J; Casorati G; Traunecker A; Iglesias A; Gutierrez JC; Müller U; Palacios R
    Eur J Immunol; 1991 Feb; 21(2):453-60. PubMed ID: 1999226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical implications of interleukin-7 and lymphopoiesis.
    Appasamy PM
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):25-39. PubMed ID: 10390077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the biology of IL-7 for therapeutic application.
    Mackall CL; Fry TJ; Gress RE
    Nat Rev Immunol; 2011 May; 11(5):330-42. PubMed ID: 21508983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells in cancer.
    Höglund P; Klein E
    Semin Cancer Biol; 2006 Oct; 16(5):331-2. PubMed ID: 16931040
    [No Abstract]   [Full Text] [Related]  

  • 9. The pleiotropic effects of interleukin 7 and their pathologic and therapeutic implications.
    Costello R; Duffaud F
    Eur J Med; 1992 May; 1(2):119-21. PubMed ID: 1342368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse immunological and hematological effects of interleukin 7: implications for clinical application.
    Komschlies KL; Grzegorzewski KJ; Wiltrout RH
    J Leukoc Biol; 1995 Dec; 58(6):623-33. PubMed ID: 7499959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sweet side of tumor immunotherapy.
    Freire T; Osinaga E
    Immunotherapy; 2012 Jul; 4(7):719-34. PubMed ID: 22853758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of a cDNA encoding ovine interleukin 7.
    Barcham GJ; Andrews AE; Nash AD
    Gene; 1995 Mar; 154(2):265-9. PubMed ID: 7890175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-7, a new immunoadjuvant for the treatment of septic shock].
    Monneret G; Villars-Méchin A; Demaret J; Foray AP; Venet F
    Med Sci (Paris); 2014 Feb; 30(2):160-5. PubMed ID: 24572114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological role and potential therapeutic application of interleukin 7.
    Krawczenko A; Kieda C; Duś D
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):518-25. PubMed ID: 16407784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly.
    Smart FM; Venkitaraman AR
    J Exp Med; 2000 Feb; 191(4):737-42. PubMed ID: 10684865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to tumor antigens and their clinical applications.
    Balch CM
    Surgery; 1986 Sep; 100(3):562-71. PubMed ID: 3488601
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-7 immunotherapy.
    Sportès C; Gress RE
    Adv Exp Med Biol; 2007; 601():321-33. PubMed ID: 17713021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interleukin 2: molecular biology, physiology and clinical possibilities.
    Mertelsmann R; Welte K
    Immunobiology; 1986 Sep; 172(3-5):400-19. PubMed ID: 3100434
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.
    Vudattu NK; Magalhaes I; Schmidt M; Seyfert-Margolis V; Maeurer MJ
    Int J Cancer; 2007 Oct; 121(7):1512-9. PubMed ID: 17546596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.